エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 2, 2023
Axcelis Technologies, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 000-30941 | 34-1818596 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
| 108 Cherry Hill Drive, Beverly, Massachusetts | 01915 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (978) 787-4000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | ACLS | NASDAQ Global Select Market |
Item 2.02 Results of Operations and Financial Condition
On August 2, 2023, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended June 30, 2023. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release dated August 2, 2023. Filed herewith. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: August 2, 2023 | Axcelis Technologies, Inc. | |
| By: | /s/ KEVIN J. BREWER | |
| Kevin J. Brewer | ||
| Executive Vice President and Chief Financial Officer | ||
Exhibit 99.1
| News Release |  |
Axcelis Announces Financial Results for Second Quarter 2023
Financial Results Exceed Guidance Driven by Strong Purion Demand and Strength in Power Devices
BEVERLY, Mass. — Aug. 2, 2023 — Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter of 2023.
Highlights include:
| · | The Company reported second quarter revenue of $274.0 million, compared to $254.0 million for the first quarter of 2023. |
| · | Operating profit for the quarter was $63.7 million, compared to $51.4 million for the first quarter. |
| · | Net income for the quarter was $61.6 million, or $1.86 per diluted share, compared to $47.7 million, or $1.43 per diluted share in the first quarter. |
| · | Gross margin for the quarter was 43.7%, compared to 40.9% in the first quarter. |
| · | Second quarter ended with systems backlog of $1.23 billion on quarterly bookings of $193 million. |
President and CEO Russell Low commented, “Axcelis delivered strong second quarter financial performance as a result of significant demand for the Purion product family, especially in the silicon carbide power market. Axcelis is the only company with a product line capable of covering all implant recipes in the mature process technology markets. This uniquely positions Axcelis for strong growth. We now believe it is possible to achieve $1.3 billion in revenue in the next one or two years, depending on market conditions.”
Executive Vice President and Chief Financial Officer Kevin Brewer said, “We are very pleased with our second quarter 2023 financial results which finished well above guidance due to solid execution and continuing strong demand for Purion. We are upwardly revising expectations for 2023 revenue to greater than $1.1 billion, representing year over year growth of approximately 20%.”
Business
Outlook
For the third quarter ending September 30, 2023, Axcelis expects revenues of
approximately $280 million. Gross margin in the third quarter is expected to be approximately 44%. Third quarter operating profit is
forecast to be approximately $64 million with earnings per diluted share of approximately $1.72. For the full year, the Company
expects to achieve revenue greater than $1.1 billion and to achieve full year gross margins of approximately 44% as shown
in the $1.1 billion model.
| News Release | |
Second
Quarter 2023 Conference Call
The Company will host a call to discuss the results for the second quarter on Thursday, August 3, 2023, at 8:30 a.m. ET. The call will
be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com,
or by registering as a Participant here: https://register.vevent.com/register/BI9757e7e7d17f4188872f4146e314ba26. Webcast replays
will be available for 30 days following the call.
Safe
Harbor Statement
This press release and the conference call contain forward-looking statements under the Private
Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for revenues, gross margin,
operating profit and other guidance for our future financial performance and spending in our industry, are based on management’s
current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results
to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that
customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue
in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we
can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with
and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs
that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could
also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating
to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time
with the Securities and Exchange Commission.
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Company Contacts
Investor Relations:
Doug Lawson
978.787.9552
Editorial/Media:
Maureen Hart
978.787.4266
| News Release | |
Axcelis Technologies, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
| Three months ended | Six months ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Revenue: | ||||||||||||||||
| Product | $ | 265,673 | $ | 213,926 | $ | 511,680 | $ | 410,458 | ||||||||
| Services | 8,297 | 7,251 | 16,310 | 14,314 | ||||||||||||
| Total revenue | 273,970 | 221,177 | 527,990 | 424,772 | ||||||||||||
| Cost of revenue: | ||||||||||||||||
| Product | 146,741 | 115,754 | 289,512 | 223,395 | ||||||||||||
| Services | 7,526 | 6,242 | 14,756 | 12,429 | ||||||||||||
| Total cost of revenue | 154,267 | 121,996 | 304,268 | 235,824 | ||||||||||||
| Gross profit | 119,703 | 99,181 | 223,722 | 188,948 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 24,130 | 18,731 | 47,903 | 35,704 | ||||||||||||
| Sales and marketing | 15,537 | 12,703 | 29,681 | 23,994 | ||||||||||||
| General and administrative | 16,328 | 13,602 | 31,073 | 26,180 | ||||||||||||
| Total operating expenses | 55,995 | 45,036 | 108,657 | 85,878 | ||||||||||||
| Income from operations | 63,708 | 54,145 | 115,065 | 103,070 | ||||||||||||
| Other income (expense): | ||||||||||||||||
| Interest income | 4,307 | 352 | 8,243 | 447 | ||||||||||||
| Interest expense | (1,349 | ) | (1,250 | ) | (2,702 | ) | (2,768 | ) | ||||||||
| Other, net | (2,050 | ) | (5,051 | ) | (3,088 | ) | (6,669 | ) | ||||||||
| Total other income (expense) | 908 | (5,949 | ) | 2,453 | (8,990 | ) | ||||||||||
| Income before income taxes | 64,616 | 48,196 | 117,518 | 94,080 | ||||||||||||
| Income tax provision | 3,037 | 4,007 | 8,242 | 8,276 | ||||||||||||
| Net income | $ | 61,579 | $ | 44,189 | $ | 109,276 | $ | 85,804 | ||||||||
| Net income per share: | ||||||||||||||||
| Basic | $ | 1.88 | $ | 1.34 | $ | 3.34 | $ | 2.59 | ||||||||
| Diluted | $ | 1.86 | $ | 1.32 | $ | 3.29 | $ | 2.54 | ||||||||
| Shares used in computing net income per share: | ||||||||||||||||
| Basic weighted average shares of common stock | 32,775 | 33,096 | 32,759 | 33,170 | ||||||||||||
| Diluted weighted average shares of common stock | 33,189 | 33,562 | 33,237 | 33,770 | ||||||||||||
| News Release | |
Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)
| June 30, | December 31, | |||||||
| 2023 | 2022 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 132,504 | $ | 185,595 | ||||
| Short-term investments | 320,360 | 246,571 | ||||||
| Accounts receivable, net | 159,199 | 169,773 | ||||||
| Inventories, net | 299,841 | 242,406 | ||||||
| Prepaid expenses and other current assets | 38,265 | 33,300 | ||||||
| Total current assets | 950,169 | 877,645 | ||||||
| Property, plant and equipment, net | 43,156 | 39,664 | ||||||
| Operating lease assets | 31,998 | 12,146 | ||||||
| Finance lease assets, net | 17,305 | 17,942 | ||||||
| Long-term restricted cash | 6,652 | 752 | ||||||
| Deferred income taxes | 38,944 | 31,701 | ||||||
| Other assets | 33,494 | 33,791 | ||||||
| Total assets | $ | 1,121,718 | $ | 1,013,641 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 60,504 | $ | 62,346 | ||||
| Accrued compensation | 17,216 | 35,540 | ||||||
| Warranty | 10,867 | 8,299 | ||||||
| Income taxes | 6,598 | 4,304 | ||||||
| Deferred revenue | 138,890 | 123,471 | ||||||
| Current portion of finance lease obligation | 1,367 | 1,229 | ||||||
| Other current liabilities | 13,018 | 12,943 | ||||||
| Total current liabilities | 248,460 | 248,132 | ||||||
| Long-term finance lease obligation | 44,455 | 45,185 | ||||||
| Long-term deferred revenue | 43,650 | 31,306 | ||||||
| Other long-term liabilities | 41,116 | 21,762 | ||||||
| Total liabilities | 377,681 | 346,385 | ||||||
| Stockholders’ equity: | ||||||||
| Common stock, $0.001 par value, 75,000 shares authorized; 32,836 shares issued and outstanding at June 30, 2023; 32,775 shares issued and outstanding at December 31, 2022 | 33 | 33 | ||||||
| Additional paid-in capital | 540,120 | 550,299 | ||||||
| Retained earnings | 206,813 | 118,892 | ||||||
| Accumulated other comprehensive loss | (2,929 | ) | (1,968 | ) | ||||
| Total stockholders’ equity | 744,037 | 667,256 | ||||||
| Total liabilities and stockholders’ equity | $ | 1,121,718 | $ | 1,013,641 | ||||